Release Date: February 11, 2026
Expiration Date: April 30, 2026
Activity Overview
This educational activity is an archive of the live presentation held from January 23, 2026, to January 25, 2026.
For more information about this educational activity, the faculty,
and disclosures, please click here.
Target Audience
This educational activity is intended for oncologists involved in the treatment and management of patients with lung cancer. Nurse practitioners, nurses, physician assistants, pharmacists, investigators, fellows, and other health care professionals interested in the treatment of lung cancer may also participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Apply current evidence-based, guideline-recommended approaches to biomarker testing to inform treatment selection in patients with lung cancer
- Evaluate efficacy and safety data from recent clinical trials on established and emerging therapeutic approaches for lung cancer
- Integrate the latest clinical evidence and guideline recommendations into the development of personalized treatment plans for patients with lung cancer
- Implement best practices to identify, prevent, and manage treatment-related adverse effects associated with novel therapies for lung cancer
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
